From Our Partners
Saturday, July 2, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Air Force Seeks White Papers for CBRN Detection, Expeditionary Medicine

by Global Biodefense Staff
March 14, 2013

711th Human Performance Wing (AFRL)The U.S. Air Force Research Laboratory has issued an annual renewal notice for a Broad Agency Announcement (BAA) seeking proposals for clinical research, aerospace medicine, human performance research and expeditionary medicine.

The effort highlights a need for advanced science and technologies that will support:

Novel methods to enhance biological or chemical agent surveillance and detection systems
High-capacity hand-held detectors for accurate identification of chem-bio threats
Informatics to improve “Detect to Warn’ biosurveillance situational awareness
Automated monitoring of indoor structures and ventilation systems for threat agents
Novel non-pharmaceutical therapeutics (e.g. hyperbaric medicine)
Health effects of emerging contaminants, desert dust and nanoparticles
Wound treatment devices for expeditionary medicine
Monitoring of subtle changes in moderate to severe traumatic brain injury patients
Field-deployable rapid and accurate radioanalytical laboratory (rugged, air-transportable)
Point-of-care laboratory diagnostics and ruggedization of diagnostic or detection platforms
Medical effects of pharmaceuticals and therapies on aircrew performance
Filter enhancements for CBRNE protective equipment

A wide range of other human performance and expeditionary medicine topics are detailed in the official solicitation. 

The BAA is overseen by the 711th Human Performance Wing. The Air Force anticipates awarding 5-6 awards per year each with an estimated value between $50,000 to $5,000,000. 

Further details are available under Solicitation Number BAA-11-01-HPW. The opportunity remains open until December 15, 2015. 

From Our Partners
Tags: BAACBRN EquipmentChemical DetectionMobile ResponseNanotechPOC DiagnosticsRuggedized

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC